The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
The role of tetramerization in p53 function
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some proteins bind directly to TET, but no complex structure has yet been demonstrated.319”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [319]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 1×
“It has been shown, for example, that several interactions at the interface with the DBD may stabilize the tetramers (Cho et al., 1994).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a001 · Cited by 2,172 · cited 1×
“For example, seven of the 20 residues of the a-helix 335 ± 354 can be mutated into proline, a well-known helix breaker (Chou and Fasman, 1974).”
Backgroundp53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Mapping of the p53 and mdm-2 interaction domains.
Chen, J., Marechal, V, & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 689
Gannon, J. V., Greaves, R., Iggo, R., & Lane, D. P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08279.x · Cited by 688
Milner, J., & Medcalf, E. A. (1991) · Cell · doi:10.1016/0092-8674(91)90384-b · Cited by 612
Crystal Structure of the Tetramerization Domain of the p53 Tumor Suppressor at 1.7 Angstroms
Jeffrey, P. D., Gorina, S., & Pavletich, N. P. (1995) · Science · doi:10.1126/science.7878469 · Cited by 549
The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
Pavletich, N. P., Chambers, K. A., & Pabo, C. O. (1993) · Genes & Development · doi:10.1101/gad.7.12b.2556 · Cited by 521
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
Marin, M. C., Jost, C. A., Brooks, L. A., Irwin, M. S., O'Nions, J., Tidy, J. A., James, N., McGregor, J. M., Harwood, C. A., Yulug, I. G., et al. (2000) · Nature Genetics · doi:10.1038/75586 · Cited by 515
p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells
Di Como, C. J., Gaiddon, C., & Prives, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1438 · Cited by 417
Blockage by Adenovirus E4orf6 of Transcriptional Activation by the p53 Tumor Suppressor
Dobner, T., Horikoshi, N., Rubenwolf, S., & Shenk, T. (1996) · Science · doi:10.1126/science.272.5267.1470 · Cited by 311
High-Resolution Structure of the Oligomerization Domain of p53 by Multidimensional NMR
Clore, G. M., Omichinski, J. G., Sakaguchi, K., Zambrano, N., Sakamoto, H., Appella, E., & Gronenborn, A. M. (1994) · Science · doi:10.1126/science.8023159 · Cited by 307
Mechanisms of p53-mediated apoptosis
Bates, S., & Vousden, K. H. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050267 · Cited by 305
Soussi, T., Dehouche, K., & B�roud, C. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<105::aid-humu19>3.0.co;2-g · Cited by 271
Bargonetti, J., Manfredi, J. J., Chen, X., Marshak, D. R., & Prives, C. (1993) · Genes & Development · doi:10.1101/gad.7.12b.2565 · Cited by 265
Solution structure of the tetrameric minimum transforming domain of p53
Lee, W., Harvey, T. S., Yin, Y., Yau, P., Litchfield, D., & Arrowsmith, C. H. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb1294-877 · Cited by 265
The p53 protein is an unusually shaped tetramer that binds directly to DNA.
Friedman, P. N., Chen, X., Bargonetti, J., & Prives, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3319 · Cited by 264
How p53 binds DNA as a tetramer
McLure, K. G., & Lee, P. W. K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3342 · Cited by 260
Liu, X., Miller, C. W., Koeffler, P. H., & Berk, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3291 · Cited by 260
Phosphorylation of Serine 392 Stabilizes the Tetramer Formation of Tumor Suppressor Protein p53
Sakaguchi, K., Sakamoto, H., Lewis, M. S., Anderson, C. W., Erickson, J. W., Appella, E., & Xie, D. (1997) · Biochemistry · doi:10.1021/bi970759w · Cited by 246
Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73
Strano, S., Munarriz, E., Rossi, M., Cristofanelli, B., Shaul, Y., Castagnoli, L., Levine, A. J., Sacchi, A., Cesareni, G., Oren, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003360200 · Cited by 240
p53 domains: identification and characterization of two autonomous DNA-binding regions.
Wang, Y., Reed, M., Wang, P., Stenger, J. E., Mayr, G., Anderson, M. E., Schwedes, J. F., & Tegtmeyer, P. (1993) · Genes & Development · doi:10.1101/gad.7.12b.2575 · Cited by 239
Mechanisms of switching on p53: a role for covalent modification?
Meek, D. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202951 · Cited by 236
Refined solution structure of the oligomerization domain of the tumour suppressor p53
Clore, G. M., Ernst, J., Clubb, R., Omichinski, J. G., Kennedy, W. M. P., Sakaguchi, K., Appella, E., & Gronenborn, A. M. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0495-321 · Cited by 222
Poly(ADP-ribose) Binds to Specific Domains of p53 and Alters Its DNA Binding Functions
Malanga, M., Pleschke, J. M., Kleczkowska, H. E., & Althaus, F. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11839 · Cited by 220
Halazonetis, T. D., & Kandil, A. N. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06199.x · Cited by 205
New approaches to understanding p53 gene tumor mutation spectra
Hollstein, M., Hergenhahn, M., Yang, Q., Bartsch, H., Wang, Z.-Q., & Hainaut, P. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00162-1 · Cited by 198
Frazier, M. W., He, X., Wang, J., Gu, Z., Cleveland, J. L., & Zambetti, G. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3735 · Cited by 194
Wild-type p53 adopts a ‘mutant’-like conformation when bound to DNA.
Halazonetis, T. D., Davis, L. J., & Kandil, A. N. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05743.x · Cited by 193
Regulation of Mdm2-Directed Degradation by the C Terminus of p53
Kubbutat, M. H. G., Ludwig, R. L., Ashcroft, M., & Vousden, K. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5690 · Cited by 193
The p53 tumour suppressor gene
Steele, R. J. C., Thompson, A. M., Hall, P. A., & Lane, D. P. (1998) · Journal of British Surgery · doi:10.1046/j.1365-2168.1998.00910.x · Cited by 183
Introduction: p53 – the first twenty years
Oren, M., & Rotter, V. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050265 · Cited by 180
Blagosklonny, M. V. (2000) · The FASEB Journal · doi:10.1096/fj.99-1078rev · Cited by 170
Mateu, M. G., & Fersht, A. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2748 · Cited by 169
Davison, T. S., Vagner, C., Kaghad, M., Ayed, A., Caput, D., & Arrowsmith, C. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18709 · Cited by 160
Dominant-negative p53 mutations selected in yeast hit cancer hot spots.
Brachmann, R. K., Vidal, M., & Boeke, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4091 · Cited by 158
Interaction of p53 with Its Consensus DNA-Binding Site
Wang, Y., Schwedes, J. F., Parks, D., Mann, K., & Tegtmeyer, P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2157 · Cited by 155
Oligomerization of oncoprotein p53
Kraiss, S., Quaiser, A., Oren, M., & Montenarh, M. (1988) · Journal of Virology · doi:10.1128/jvi.62.12.4737-4744.1988 · Cited by 147
Waterman, J. L. F., Shenk, J. L., & Halazonetis, T. D. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07027.x · Cited by 144
Signaling to p53: breaking the posttranslational modification code.
Appella, E., & Anderson, C. W. (2000) · PubMed · Cited by 141
Johnson, C. R., Morin, P. E., Arrowsmith, C. H., & Freire, E. (1995) · Biochemistry · doi:10.1021/bi00016a002 · Cited by 138
Oligomerization Is Required for p53 to be Efficiently Ubiquitinated by MDM2
Maki, C. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16531 · Cited by 130
Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA.
Balagurumoorthy, P., Sakamoto, H., Lewis, M. S., Zambrano, N., Clore, G. M., Gronenborn, A. M., Appella, E., & Harrington, R. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8591 · Cited by 129
p53: A Cell Cycle Regulator Activated by DNA Damage
Selivanova, G., & Wiman, K. G. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60253-5 · Cited by 128
Nagaich, A. K., Zhurkin, V. B., Durell, S. R., Jernigan, R. L., Appella, E., & Harrington, R. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1875 · Cited by 127
Levine, A. J., Wu, M. C., Chang, A., Silver, A., Attiyeh, E. F., Lin, J., & Epstein, C. B. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb12115.x · Cited by 116
Davison, T. S., Yin, P., Nie, E., Kay, C. M., & Arrowsmith, C. H. (1998) · Oncogene · doi:10.1038/sj.onc.1202062 · Cited by 112
Formation of stable p53 homotetramers and multiples of tetramers
Stenger, J. E., Mayr, G. A., Mann, K., & Tegtmeyer, P. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940050204 · Cited by 104
p53 oligomerization and DNA looping are linked with transcriptional activation.
Stenger, J. E., Tegtmeyer, P., Mayr, G. A., Reed, M., Wang, Y., Wang, P., Hough, P. V., & Mastrangelo, I. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06947.x · Cited by 100
Lomax, M. E., Barnes, D. M., Hupp, T. R., Picksley, S. M., & Camplejohn, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201974 · Cited by 100
Mechanism of folding and assembly of a small tetrameric protein domain from tumor suppressor p53.
Fersht, A. R., Mateu, M. G., & del Pino, M. M. S. (1999) · Nature Structural Biology · doi:10.1038/5880 · Cited by 98
Interaction between the HPV-16 E2 transcriptional activator and p53
Massimi, P., Pim, D., Bertoli, C., Bouvard, V., & Banks, L. (1999) · Oncogene · doi:10.1038/sj.onc.1203208 · Cited by 98
SV40 T antigen binds specifically to a cellular 53 K protein in vitro
McCormick, F. P., Clark, R., Harlow, E., & Tjian, R. (1981) · Nature · doi:10.1038/292063a0 · Cited by 94
Schmieg, F. I., & Simmons, D. T. (1988) · Virology · doi:10.1016/0042-6822(88)90628-9 · Cited by 88
p300/CBP-Dependent and -Independent Transcriptional Interference between NF-κB RelA and p53
Ikeda, A., Sun, X., Li, Y., Zhang, Y.-K., Eckner, R., Doi, T. S., Takahashi, T., Obata, Y., Yoshioka, K., & Yamamoto, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2786 · Cited by 87
Mutant p53: Gain-of-Function Oncoproteins and Wild-Type p53 Inactivators
Roemer, K. (1999) · Biological Chemistry · doi:10.1515/bc.1999.108 · Cited by 87
Lányi, Á., Deb, D., Seymour, R. C., Ludes-Meyers, J. H., Subler, M. A., & Deb, S. (1998) · Oncogene · doi:10.1038/sj.onc.1201857 · Cited by 87
Shaulian, E., Zauberman, A., Milner, J., Davies, E. A., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05940.x · Cited by 78
Mateu, M. G., & Fersht, A. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3595 · Cited by 74
Temperature-dependent switching between “wild-type” and “mutant” forms of p53-Val135
Milner, J., & Medcalf, E. (1990) · Journal of Molecular Biology · doi:10.1016/0022-2836(90)90371-r · Cited by 73
Stimulation of p53 DNA Binding by c-Abl Requires the p53 C Terminus and Tetramerization
Nie, Y., Li, H.-H., Bula, C. M., & Liu, X. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.741-748.2000 · Cited by 73
In vitro analysis of the dominant negative effect of p53 mutants
Chêne, P. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1897 · Cited by 72
Self-citationMittl, P. R. E., Chêne, P., & Grütter, M. G. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444997006550 · Cited by 71
Self-citationLomax, M. E., Barnes, D. M., Gilchrist, R., Picksley, S. M., Varley, J. M., & Camplejohn, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201133 · Cited by 65
Interhelical Angles in the Solution Structure of the Oligomerization Domain of p53: Correction
Clore, G. M., Omichinski, J. G., Sakaguchi, K., Zambrano, N., Sakamoto, H., Appella, E., & Gronenborn, A. M. (1995) · Science · doi:10.1126/science.7878474 · Cited by 60
p53 DNA binding can be modulated by factors that alter the conformational equilibrium
McLure, K. G., & Lee, P. W. K. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.763 · Cited by 53
Sakamoto, H., Lewis, M. S., Kodama, H., Appella, E., & Sakaguchi, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8974 · Cited by 53
The in Vitro Phosphorylation of P53 by Calcium‐Dependent Protein Kinase C
Delphi, C., Huang, K., Scotto, C., Chapel, A., Vinçon, M., CHAMBAZ, E. M., Garin, J., & Baudier, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00684.x · Cited by 44
McCoy, M. A., Stavridi, E. S., Waterman, J. L. F., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6230 · Cited by 43
The oligomerization domain of p53: Crystal structure of the trigonal form
Miller, M., Lubkowski, J. T., Rao, J., Danishefsky, A. T., Omichinski, J. G., Sakaguchi, K., Sakamoto, H., Appella, E., Gronenborn, A. M., & Clore, G. M. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01231-8 · Cited by 42
Protein kinase CK2 interacts with a multi-protein binding domain of p53
Götz, C., Scholtes, P., Prowald, A., Schuster, N., Nastainczyk, W., & Montenarh, M. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006886727248 · Cited by 38
In vitro structure-function analysis of the β-strand 326-333 of human p53 1 1Edited by A. Fersht
Chêne, P., Mittl, P. R. E., & Grütter, M. G. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1360 · Cited by 32
Self-citationRollenhagen, C., & Chêne, P. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981029)78:3<372::aid-ijc19>3.0.co;2-8 · Cited by 27
Self-citationIshioka, C., Shimodaira, H., Englert, C., Shimada, A., Osada, M., Jia, L.-Q., Suzuki, T., Gamo, M., & Kanamaru, R. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6216 · Cited by 26
Chêne, P., & Bechter, E. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2738 · Cited by 17
Self-citationStavridi, E. S., Caruso, L. C., Chehab, N. H., & Halazonetis, T. D. (1999) · Protein Science · doi:10.1110/ps.8.9.1773 · Cited by 15
Influence of the N-terminal region on the oligomerisation between human and Xenopus laevis p53
Chêne, P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2734 · Cited by 4
Self-citationSurridge, C. D. (1994) · Nature · doi:10.1038/372482a0 · Cited by 1
(2000) · Journal of Psychology and Theology · doi:10.1177/009164710002800307 · Cited by 1
(2000) · PubMed
Cited by
Intrinsically Disordered Proteins in Human Diseases: Introducing the D2Concept
Uversky, V. N., Oldfield, C. J., & Dunker, A. K. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125924 · Cited by 1,410
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Structural Biology of the Tumor Suppressor p53
Joerger, A. C., & Fersht, A. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.060806.091238 · Cited by 693
Malkin, D. (2011) · Genes & Cancer · doi:10.1177/1947601911413466 · Cited by 508
Arginine methylation regulates the p53 response
Jansson, M., Durant, S. T., Cho, E.-C., Sheahan, S., Edelmann, M., Kessler, B., & La Thangue, N. B. (2008) · Nature Cell Biology · doi:10.1038/ncb1802 · Cited by 462
Metadata
- Authors
- Chène, P.
- Venue
- Oncogene
- Published
- 2001-05-10
- Volume
- 20
- Issue
- 21
- Pages
- 2611-2617
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2061658069
- Cited by
- 271
- References
- 87
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.